City
Epaper

Ensure uniformity in Covid-19 testing rates across country, SC to Centre

By IANS | Updated: June 19, 2020 14:42 IST

The Supreme Court told the Centre on Friday that there should be uniformity in Covid-19 testing rates of all ...

Open in App

The Supreme Court told the Centre on Friday that there should be uniformity in Covid-19 testing rates of all the state governments, and it should coordinate on this.

A bench comprising Justices Ashok Bhushan, Sanjay Kishan Kaul and M.R. Shah directed the Centre to set up a committee to fix Covid testing rates state-wise.

"In some states it is Rs 2,200 and in some it is Rs 4,500. We will not fix a rate. You fix a rate," Justice Shah told Solicitor General Tushar Mehta, representing the Centre.

Mehta replied that it is better to leave it to the states, as some may be discussing to have even lower rates for testing.

The bench said, "You fix the upper limit. States will do the rest."

Justice Bhushan also emphasised that reasonable rates be fixed for Covid-19 tests, and there must be uniformity across the country.

The bench was hearing a case where it took suo moto cognizance of lapses in Covid-19 patient care and mishandling of bodies.

( With inputs from IANS )

Tags: Tushar MehtaSanjay Kishan KaulSupreme Court
Open in App

Related Stories

NationalWho Is Harish Rana? Man in Coma for 12 Years Gets Right to Die After Supreme Court Order

MumbaiMumbai: Retired Bank Manager, Family Held in ‘Digital Arrest’ for 35 Days; ₹1.83 Crore Lost to Cyber Fraud in Mulund

InternationalDonald Trump's Global Tariffs Illegal : US Supreme Court Deals Major Blow to President

EntertainmentNeeraj Pandey Drops ‘Ghooskhor Pandat’ Title; Supreme Court Closes Case

InternationalRamadan 2026 Moon Sighting in Saudi Arabia: Supreme Court of KSA Calls on Muslims to Search for Crescent on THIS Date

Health Realted Stories

HealthGujarat: Hotels, eateries fined for paneer display violations; 615 kg of substandard food destroyed

HealthMinistry of Social Justice clocks highest-ever Rs 11,810 crore expenditure in FY26

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support

HealthIndia clocks unprecedented foodgrain output, boosts institutional support to farmers

HealthIndia tightens watch on GLP-1 drugs amid safety and misuse concerns